The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADC THERAPEUTICS SA | SHS | H0036K147 | 4,028 | 125,850 | SH | SOLE | NONE | 125,850 | 0 | 0 | |
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 4,654 | 81,357 | SH | SOLE | NONE | 81,357 | 0 | 0 | |
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 4,652 | 336,384 | SH | SOLE | NONE | 336,384 | 0 | 0 | |
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 134 | 15,006 | SH | SOLE | NONE | 15,006 | 0 | 0 | |
AVROBIO INC | COM | 05455M100 | 2,031 | 145,715 | SH | SOLE | NONE | 145,715 | 0 | 0 | |
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 8,237 | 1,105,673 | SH | SOLE | NONE | 1,105,673 | 0 | 0 | |
BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | 1,118 | 34,891 | SH | SOLE | NONE | 34,891 | 0 | 0 | |
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 3,162 | 224,129 | SH | SOLE | NONE | 224,129 | 0 | 0 | |
CYTOKINETICS INC | COM | 23282W605 | 5,113 | 246,036 | SH | SOLE | NONE | 246,036 | 0 | 0 | |
EPIZYME INC | COM | 29428V104 | 10,105 | 930,467 | SH | SOLE | NONE | 930,467 | 0 | 0 | |
FREQUENCY THERAPEUTICS INC | COM | 35803L108 | 4,395 | 124,650 | SH | SOLE | NONE | 124,650 | 0 | 0 | |
FULCRUM THERAPEUTICS INC | COM | 359616109 | 3,184 | 271,926 | SH | SOLE | NONE | 271,926 | 0 | 0 | |
G1 THERAPEUTICS INC | COM | 3621LQ109 | 2,118 | 117,708 | SH | SOLE | NONE | 117,708 | 0 | 0 | |
INOZYME PHARMA INC | COM | 45790W108 | 3,525 | 170,796 | SH | SOLE | NONE | 170,796 | 0 | 0 | |
INSMED INC | COM | 457669307 | 5,145 | 154,562 | SH | SOLE | NONE | 154,562 | 0 | 0 | |
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 3,486 | 64,079 | SH | SOLE | NONE | 64,079 | 0 | 0 | |
IVERIC BIO INC | COM | 46583P102 | 9,592 | 1,388,136 | SH | SOLE | NONE | 1,388,136 | 0 | 0 | |
MEI PHARMA INC | COM | 55279B202 | 8,464 | 3,205,938 | SH | SOLE | NONE | 3,205,938 | 0 | 0 | |
MERUS N V | COM | N5749R100 | 2,291 | 130,683 | SH | SOLE | NONE | 130,683 | 0 | 0 | |
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 2,822 | 161,628 | SH | SOLE | NONE | 161,628 | 0 | 0 | |
NEOGENOMICS INC | COM | 64049M209 | 9,625 | 178,777 | SH | SOLE | NONE | 178,777 | 0 | 0 | |
PROTALIX BIOTHERAPEUTICS INC | COM | 74365A309 | 8,967 | 2,470,332 | SH | SOLE | NONE | 2,470,332 | 0 | 0 | |
PTC THERAPEUTICS INC | COM | 69366J200 | 9,831 | 161,083 | SH | SOLE | NONE | 161,083 | 0 | 0 | |
TURNING POINT THERAPEUTICS I | COM | 90041T108 | 8,832 | 72,484 | SH | SOLE | NONE | 72,484 | 0 | 0 | |
Y-MABS THERAPEUTICS INC | COM | 984241109 | 5,692 | 114,962 | SH | SOLE | NONE | 114,962 | 0 | 0 |